- Medical Devices
- Wednesday, 14 Apr 2021
Europe Microtome Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Product (Microtome Instruments,Rotary Microtomes,Cryostat Microtomes,Vibrating Microtomes,Other Microtome Instruments,Microtome Accessories); By End User (Hospitals,Clinical Laboratories,Other End Users) and Geography
According to The Insight Partners market research study of “Europe Microtome Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product, Technology and End User,” the Europe microtome market is expected to reach US$ 58,738.7 thousand in 2027 from US$ 38,985.9 thousand in 2019. The market is predicted to grow with a CAGR of 5.4% from 2020-2027. The report highlights trends prevailing in the Europe microtome market and the factors driving the market along with those that act as hindrances.
Request For Sample Reports @ https://www.theinsightpartners.com/sample/TIPRE00013019/
Company Profiles
- PHC Holdings Corporation
- MEDITE Medical GmbH
- Leica Biosystems Nussloch GmbH (Danaher)
- Histo-Line Laboratories
- SLEE medical GmbH
Based on the product, the Europe microtome market is further segmented into the microtome instrument and microtome accessories. The microtome instrument segment held a larger share of the market in 2019. This attributes to the increasing prevalence of cancer and the rising adoption of advanced diagnostic tools in the disease diagnosis. Also, increasing research activities such as drug discovery, novel therapeutics, and expansion of product lines are further expanding the market share of the segment. Microtome is a sectioning instrument that enables the cutting of thin slices of a substance known as the slice. Microtome is utilized in microscopy, allowing for the formation of the sample for investigation under transmitted light. Microtome use glass, steel, and diamond blades are depending upon the specimen being sliced and the aspired thickness of the part being cut.
Europe microtome market is expected to grow owing to factors such as the rising prevalence of cancer, and increasing adoption of digital pathology is expected to propel the growth of the market. However, the lack of skilled professionals is the major factor hindering the market growth.
PHC Holdings Corporation, MEDITE Medical GmbH, Leica Biosystems Nussloch GmbH (Danaher), Histo-Line Laboratories, and SLEE medical GmbH is among the leading companies operating in the Europe microtome market.
Europe Microtome Market– Market Segmentation
By Product
- Microtome Instruments
- Rotary Microtomes
- Cryostat Microtomes
- Vibrating Microtomes
- Other Microtome Instruments
- Microtome Accessories
By Technology
- Manual Microtomes
- Semi-automated Microtomes
- Fully Automated Microtomes
By End User
- Hospitals
- Clinical Laboratories
- Other End Users
By Country
- UK
- Germany
- France
- Italy
- Spain
You Can Buy This Report from Here@ https://www.theinsightpartners.com/buy/TIPRE00013019/
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
Related Industry Updates
Asia Pacific Medical Headwalls Market Outstanding Rise during 2019-2027 with CAGR Value 6.2%| Business Market Insights
Mar 09, 2021
COPD Devices Market is expected to reach US$ 12,877.43 million by 2030
Jan 04, 2024
Pharmaceutical Solvent Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Chemical Group (Alcohol, Amine, Esters, Ethers, Chlorinated Solvents, Others)
Apr 26, 2021
How Coronavirus Pandemic Will Impact Asia Pacific Antibiotics Market? Industry Trends and Developments 2020-2027
Dec 17, 2020
Bone Sialoprotein I Market to Receive Overwhelming Hike in Revenues by 2027
Dec 21, 2020
Global Corporate Wellness Market by Manufacturers, Regions, Type and Application, Forecast To 2026 – Virgin Pulse, Compsych Corporation, Aduro, Inc, Beacon Health Options, Exos
Mar 11, 2021
Real World Cases Prove that XARELTO lessens the risk of recurrent venous thromboembolism in Patients with Morbidly Obesity
Sep 23, 2019